HIF1A and breast cancer: We observed a similar dichotomy in HER2-positive breast cancers, where a favourable WWOX/HIF1A ratio facilitates robust DNA repair and counteracts hypoxia-induced signalling, which would otherwise promote angiogenesis and glycolytic reprogramming linked to poor prognosis.